Form 4 for KLRS Kalaris Therapeutics, Inc.
Accepted 2022-04-22 00:00:00 ET · period of report 2022-04-21 · accession 0000899243-22-015395 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-22 | 2022-04-21 | KLRS | Hallal David | Dir, 10% | S - Sale | $5.87 | -4,227 | 2.14M | -0.2% | -$24.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-21 | S | D | 4,227 | $5.87 | 2,143,614 | D | — | — |